A chromatographic determination of aripiprazole using HPLC and UPLC: A comparative validation study

Indian Journal of Pharmaceutical Sciences

Volumn 73, Issue 4, 2011, Pages 439-443

  Thakkar, R S ^a   Saravaia, H T ^a   Ambasana, M A ^a   Kaila, H O ^a   Shah, A K ^a  

^a SAURASHTRA UNIVERSITY   (India)

Author keywords

Aripiprazole; high performance liquid chromatography; ultra performance liquid chromatography; validation

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; ARIPIPRAZOLE;

ACCURACY; ARTICLE; COMPARATIVE STUDY; DRUG STRUCTURE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; SENSITIVITY AND SPECIFICITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDITY;

EID: 84862093308     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.95638     Document Type: Article

References (20)

1. Miranda H. FDA OKs Abilify for Depression. WebMD. Available from: http://www.webmd.com/depression/news/20071120/fda-oks-abilify-fordepression. [Last accessed on 2007 Nov 20].
2. Patent and Exclusivity Search Results, Electronic Orange Book, US Food and Drug Administration. Available from: http://www. accessdata.fda.gov/scripts/ cder/ob/docs/patexclnew.cfm?Appl- No=021436andProduct-No=001andtable1=OB-Rx.
3. Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003;160:1651-8.
4. Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, et al. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: A 3-week placebo-controlled study. J Psychopharmacol (Oxford) 2006;20:536-46.
5. Vieta E, T'joen C, McQuade RD, Carson WH, Marcus RN, Sanchez R, et al. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/ lithium monotherapy: A placebo-controlled study. Am J Psychiatry 2008;165:1316-25.
6. Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, et al. Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord 2009;112:36-49.
7. Keck PE, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo. J Clin Psychiatry 2007;68:1480-91.
8. Keck PE, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 2006;67:626-37.
9. Stability Testing of New Drug Substances and Products Proceedings of the International Conference on Harmonization, International Federation of Pharmaceutical Manufacturers Association, Geneva, Switzerland 2003.
10. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use Guideline on Validation of Analytical Procedure-Methodology ICH, Geneva, Switzerland 1996.
11. Rao DV, Shetty S, Satheesh K, Radhakrishnanand P, Himabindu V. A stability indicating RPLC method for aripiprazole. Indian J Anal Chem 2008;7:444-53.
12. Vijaya kumar M, Muley PR. Determination of aripiprazole in bulk drug and solid dosage forms by RP-HPLC method. Indian Pharm 2005;4: 71-5.
13. Koduri SV, Buchireddy SR, Madhusudhan G, Mukkanti K, Srinivasulu P. Stress degradation Studies on aripiprazole and development of a validated stability indicating LC method. Chromatographia 2008;68:635-40.
14. Liu H, Jiang Y, Hao X. Determination of aripiprazole by nonaqueous reversed-phase high performance liquid chromatography. Se Pu 2005;23:563.
15. Sastry BS, Gananadhamu S, Devala RG. RP-HPLC determination of aripiprazole in Pharmaceutical formulations. Asian J Chem 2009;21:6643-6.
16. Kirschbaum KM, Muller MJ, Zernig G. Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection. Clin Chem 2005;51:1718-21.
17. Lancelin F, Djebrani K, Tabaouti K, Kraoul L, Brovedani S, Paubel P, et al. Development and validation of a high-performance chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma. J Chromatogr B 2008;867:15-9.
18. Musenga A, Saracino MA, Spinelli D, Rizzato E, Boncompagni G, Kenndler E, et al. Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection. Anal Chim Acta 2008;612:204-21.
19. Shimokawa Y, Akiyama H, Kashiyama E, Koga T, Miyamoto G. High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: Application to the pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2005;821:8-14.
20. Zuo XC, Wang F, Xu P, Zhu RH, Li HD. LC-ESI-MS for Rapid and Sensitive Determination of Aripiprazole in Human Plasma. Chromatographia 2006,64:387-91.